Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation

HAEMATOLOGICA

FERRATA STORTI FOUNDATION

1. The Henry J. Predolin Foundation for Research in Leukemia, Mayo Clinic, Rochester, MN, USA
2. CTSA Grant from the National Center for Advancing Translational Science (NCATS) [KL2 TR000136]